Soni Medicare (BSE 539378)₹69.35−4.99%Hospital
In the Mar 2026 quarter (standalone), Soni Medicare reported sales of ₹6.56 Cr, down 12.5% from Mar 2025, and net profit of −₹0.38 Cr, down 205.6% year on year. For the year to Mar 2026, sales were ₹26.16 Cr and net profit −₹2.72 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.71 | 7.95 | 5.64 | 7.12 | 7.26 | 8.57 | 7.77 | 7.50 | 7.46 | 6.49 | 5.63 | 6.56 |
| Expenses | 7.32 | 7.62 | 6.29 | 7.63 | 7.86 | 7.74 | 7.54 | 6.84 | 7.41 | 7.04 | 6.33 | 6.41 |
| Operating Profit | 0.43 | 0.36 | −0.60 | −0.46 | −0.55 | 0.86 | 0.25 | 0.69 | 0.08 | −0.50 | −0.65 | 0.17 |
| OPM % | 5.7% | 4.6% | −10.9% | −6.6% | −7.7% | 10.1% | 3.3% | 9.3% | 1.2% | −7.9% | −11.7% | 2.7% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.19 | 0.18 | 0.16 | 0.27 | 0.17 | 0.27 | 0.23 | 0.28 | 0.24 | 0.26 | 0.33 | 0.35 |
| Depreciation | 0.14 | 0.14 | 0.14 | 0.14 | 0.13 | 0.12 | 0.13 | 0.16 | 0.14 | 0.14 | 0.14 | 0.14 |
| Profit before tax | 0.10 | 0.04 | −0.90 | −0.87 | −0.85 | 0.47 | −0.09 | 0.25 | −0.28 | −0.90 | −1.12 | −0.30 |
| Tax % | 18.2% | 40.1% | −1.1% | 2.3% | 1.2% | 2.1% | 30.1% | −34.6% | 0.0% | 1.1% | 0.0% | 19.4% |
| Net Profit | 0.10 | 0.04 | −0.92 | −0.90 | −0.88 | 0.48 | −0.14 | 0.36 | −0.30 | −0.93 | −1.14 | −0.38 |
| EPS (Rs) | 0.22 | 0.08 | −2.12 | −2.10 | −2.03 | 1.11 | −0.29 | 0.83 | −0.69 | −2.15 | −2.66 | −0.88 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.30 | 13.05 | 12.58 | 13.62 | 14.24 | 14.64 | 22.52 | 27.45 | 27.15 | 29.75 | 26.16 | 26.14 |
| Expenses | 14.26 | 12.08 | 11.52 | 13.24 | 14.23 | 14.08 | 22.51 | 27.79 | 28.82 | 29.99 | 27.21 | 27.19 |
| Operating Profit | 1.11 | 1.03 | 1.11 | 0.44 | 0.09 | 0.63 | 0.15 | −0.20 | −1.51 | −0.07 | −0.90 | −0.90 |
| OPM % | 7.3% | 7.9% | 8.8% | 3.3% | 0.7% | 4.3% | 0.7% | −0.8% | −5.6% | −0.3% | −3.5% | −3.4% |
| Other Income | 0.29 | 0.38 | −0.28 | 0.25 | 0.59 | 0.28 | 0.68 | 0.97 | 1.28 | 1.36 | 0.00 | 0.00 |
| Interest | 0.40 | 0.46 | 0.52 | 0.52 | 0.64 | 0.78 | 0.71 | 0.70 | 0.84 | 0.98 | 1.21 | 1.18 |
| Depreciation | 0.78 | 0.80 | 0.75 | 0.77 | 0.77 | 0.75 | 0.79 | 0.67 | 0.53 | 0.51 | 0.52 | 0.56 |
| Profit before tax | 0.21 | 0.14 | −0.41 | −0.59 | −0.72 | −0.61 | −0.66 | −0.61 | −1.61 | −0.21 | −2.63 | −2.60 |
| Tax % | 18.2% | 40.0% | −173.7% | 11.7% | 74.1% | −8.0% | −10.4% | 9.8% | 3.1% | −18.1% | 2.7% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.19 | 0.11 | 0.32 | −0.68 | −1.28 | −0.58 | −0.61 | −0.68 | −1.69 | −0.20 | −2.72 | −2.75 |
| EPS (Rs) | 0.43 | 0.24 | 0.74 | −1.56 | −2.97 | −1.35 | −1.42 | −1.58 | −3.95 | −0.46 | −6.36 | −6.38 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.26 | 4.25 | 4.27 | 4.27 | 4.25 | 4.26 | 4.27 | 4.26 | 4.27 | 4.26 | 4.26 | 4.27 |
| Reserves | 2.54 | 2.38 | 2.51 | 2.83 | 2.16 | 0.89 | 0.32 | −0.30 | −0.97 | −2.65 | −2.97 | −5.50 |
| Borrowings | 4.34 | 3.32 | 4.09 | 3.98 | 5.31 | 6.11 | 7.11 | 7.34 | 8.72 | 9.78 | 10.51 | 12.93 |
| Other Liabilities | 3.19 | 3.38 | 3.21 | 2.88 | 3.12 | 5.15 | 5.34 | 7.62 | 8.12 | 8.33 | 10.39 | 15.04 |
| Total Liabilities | 14.33 | 13.33 | 14.08 | 13.96 | 14.84 | 16.41 | 17.04 | 18.92 | 20.14 | 19.72 | 22.19 | 26.74 |
| Fixed Assets | 7.72 | 8.02 | 7.53 | 6.94 | 7.01 | 6.97 | 6.61 | 6.69 | 6.43 | 6.18 | 6.32 | 6.11 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.58 |
| Other Assets | 6.61 | 5.31 | 6.51 | 6.62 | 7.79 | 9.40 | 10.39 | 12.20 | 13.68 | 13.51 | 15.84 | 20.05 |
| Inventories | 2.45 | 1.24 | 1.09 | 1.09 | 1.34 | 1.57 | 1.15 | 0.72 | 0.47 | 0.52 | 0.88 | 0.84 |
| Trade receivables | 0.58 | 0.74 | 2.15 | 1.68 | 1.83 | 3.02 | 3.97 | 6.24 | 7.80 | 7.07 | 8.74 | 12.71 |
| Cash & equivalents | 0.95 | 0.62 | 0.35 | 0.58 | 1.11 | 0.82 | 0.93 | 0.61 | 0.88 | 1.31 | 2.02 | 1.90 |
| Total Assets | 14.33 | 13.33 | 14.08 | 13.96 | 14.84 | 16.41 | 17.04 | 18.92 | 20.14 | 19.72 | 22.19 | 26.74 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.88 | 0.31 | −0.06 | 1.35 | 0.66 | −0.12 | 3.26 | −2.30 | 0.20 | 0.38 | 1.46 | −0.25 |
| Cash from investing activity | −0.28 | −1.15 | −0.26 | −0.28 | −0.46 | −0.64 | −0.28 | −0.72 | −0.24 | −0.16 | −0.51 | −1.06 |
| Cash from financing activity | −5.11 | 0.50 | 0.07 | −0.85 | 0.32 | 0.50 | −2.86 | 2.71 | 0.32 | 0.20 | −0.25 | 1.20 |
| Net cash flow | −0.52 | −0.34 | −0.28 | 0.24 | 0.54 | −0.30 | 0.12 | −0.33 | 0.28 | 0.44 | 0.72 | −0.13 |
| Capex | 1.30 | 1.42 | 0.28 | 0.12 | 0.51 | 0.69 | 0.37 | 0.92 | 0.38 | 0.26 | 0.65 | 0.32 |
| Free cash flow | 4.31 | −1.10 | −0.35 | 0.87 | 0.16 | −0.81 | 2.88 | −3.14 | −0.17 | 0.11 | 0.80 | −0.54 |
| CFO / OP % | 331.0% | 29.0% | −3.0% | 129.0% | 153.0% | −130.0% | 511.1% | −1,444.0% | −100.0% | −26.0% | −1,838.0% | 29.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 14 | 19 | 61 | 50 | 50 | 78 | 100 | 102 | 105 | 96 | 108 | 178 |
| Inventory days | 164 | 101 | 168 | 232 | 328 | 234 | 156 | 36 | 21 | 24 | 38 | 46 |
| Days payable | 115 | 129 | 226 | 276 | 307 | 407 | 372 | 241 | 226 | 223 | 289 | 546 |
| Cash conversion cycle | 61 | −11 | 1 | 4 | 70 | −96 | −118 | −105 | −102 | −106 | −144 | −324 |
| Working capital days | −73 | −71 | −46 | −53 | −50 | −28 | −86 | −7 | 0 | 28 | 17 | 1 |
| ROCE % | 9.9% | 6.0% | 6.0% | 4.7% | −0.6% | −0.7% | 1.5% | 0.4% | 0.8% | −6.6% | 6.6% | −12.1% |
For the Mar 2026 quarter, Soni Medicare reported sales of ₹6.56 Cr, down 12.5% year on year and net profit of −₹0.38 Cr, down 205.6% year on year. The operating margin was 2.7%.
Soni Medicare's sales for the year to Mar 2026 were ₹26.16 Cr; over the last twelve months they were ₹26.14 Cr.
Net profit for the year to Mar 2026 was −₹2.72 Cr, and −₹2.75 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−6.38.
Soni Medicare reported borrowings of ₹12.93 Cr at Mar 2026, against cash and equivalents of ₹1.90 Cr.
Cash from operations was −₹0.25 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.54 Cr.